Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Intellia Therapeutics, Inc. NTLA |
BLACKROCK INC BLK |
8,453,014 8.200% |
-557,681 (-6.19%) |
Filing History |
| 2025-01-08 11:29 am Purchase |
2024-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
The Vanguard Group | 10,189,953 10.000% |
1,842,504 (+22.07%) |
Filing History |
| 2024-02-13 5:07 pm Purchase |
2023-12-29 | 13G | Intellia Therapeutics, Inc. NTLA |
The Vanguard Group | 8,347,449 9.320% |
537,223 (+6.88%) |
Filing History |
| 2024-01-29 4:00 pm Purchase |
2023-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
ARK Investment Management LLC | 11,412,449 12.740% |
1,991,667 (+21.14%) |
Filing History |
| 2024-01-24 11:21 am Purchase |
2023-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
STATE STREET CORP STT |
4,735,861 5.290% |
3,042,392 (+179.65%) |
Filing History |
| 2024-01-08 4:35 pm Purchase |
2023-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
BLACKROCK INC BLK |
9,010,695 10.100% |
1,755,774 (+24.20%) |
Filing History |
| 2023-02-10 12:41 pm Purchase |
2022-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
ARK Investment Management LLC | 9,420,782 11.200% |
1,503,900 (+19.00%) |
Filing History |
| 2023-02-09 11:22 am Purchase |
2022-12-30 | 13G | Intellia Therapeutics, Inc. NTLA |
The Vanguard Group | 7,810,226 9.280% |
1,367,871 (+21.23%) |
Filing History |
| 2023-02-09 11:18 am Sale |
2023-02-09 | 13G | Intellia Therapeutics, Inc. NTLA |
FMR CORP | 2,421,952 2.879% |
-1,455,820 (-37.54%) |
Filing History |
| 2023-01-25 10:36 am Purchase |
2022-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
BLACKROCK INC BLK |
7,254,921 8.700% |
1,634,545 (+29.08%) |
Filing History |
| 2022-02-14 06:05 am Sale |
2021-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
Nikko Asset Management Americas, Inc. | 2,753,903 3.700% |
-2,350,459 (-46.05%) |
Filing History |
| 2022-02-11 4:06 pm Purchase |
2021-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
REGENERON PHARMACEUTICALS INC REGN |
3,702,995 4.980% |
925,218 (+33.31%) |
Filing History |
| 2022-02-10 08:17 am Purchase |
2021-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
The Vanguard Group | 6,442,355 8.660% |
1,311,158 (+25.55%) |
Filing History |
| 2022-02-09 2:38 pm Purchase |
2021-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
ARK Investment Management LLC | 7,916,882 10.640% |
274,430 (+3.59%) |
Filing History |
| 2022-02-09 09:19 am Purchase |
2022-02-08 | 13G | Intellia Therapeutics, Inc. NTLA |
FMR CORP | 3,877,772 5.210% |
3,719,166 (+2344.91%) |
Filing History |
| 2022-02-04 06:05 am Sale |
2021-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
Sumitomo Mitsui Trust Group, Inc. | 2,753,903 3.700% |
-2,350,459 (-46.05%) |
Filing History |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
BLACKROCK INC BLK |
5,620,376 7.600% |
567,531 (+11.23%) |
Filing History |
| 2021-11-26 3:23 pm Sale |
2021-10-31 | 13G | Intellia Therapeutics, Inc. NTLA |
ARK Investment Management LLC | 7,642,452 10.400% |
-3,549,218 (-31.71%) |
Filing History |
| 2021-02-16 4:33 pm Purchase |
2020-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
ARK Investment Management LLC | 11,191,670 17.400% |
2,450,238 (+28.03%) |
Filing History |
| 2021-02-11 4:24 pm Sale |
2020-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
Nikko Asset Management Americas, Inc. | 5,104,362 7.940% |
-318,856 (-5.88%) |
Filing History |